This week, Mark is taking a break so Kate, Henry and Gary will discuss gabapentinoids and the risk of severe COPD, rehab after an initial anterior shoulder dislocation, and cognitive enhancers for patients with Alzheimer’s dementia

This week, Mark is taking a break so Kate, Henry and Gary will discuss gabapentinoids and the risk of severe COPD, rehab after an initial anterior shoulder dislocation, and cognitive enhancers for patients with Alzheimer’s dementia

This week, Mark is taking a break so Kate, Henry and Gary will discuss gabapentinoids and the risk of severe COPD, rehab after an initial anterior shoulder dislocation, and cognitive enhancers for patients with Alzheimer’s dementia&nbsp;

Episode 153: gabapentinoids and COPD, shoulder dislocations, and older Alzheimer's drugs

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 153: gabapentinoids and COPD, shoulder dislocations, and older Alzheimer's drugs

Sign up to save your podcasts

Episode 153: gabapentinoids and COPD, shoulder dislocations, and older Alzheimer's drugs

Episode 153: gabapentinoids and COPD, shoulder dislocations, and older Alzheimer's drugs